Combating Pseudomonas aeruginosa Biofilms by a Chitosan-PEG-Peptide Conjugate via Changes in Assembled Structure-Reference-Cited by-同舟云学术

Combating Pseudomonas aeruginosa Biofilms by a Chitosan-PEG-Peptide Conjugate via Changes in Assembled Structure

Published:2020-03-10 Issue:12 Volume:12 Page:13731-13738
ISSN:1944-8244
Container-title:ACS Applied Materials & Interfaces
language:en
Short-container-title:ACS Appl. Mater. Interfaces

Author:

Ju Xiaoyan¹²,Chen Jun³,Zhou Mengxue³,Zhu Meng¹^ORCID,Li Zhuang¹,Gao Sijia¹,Ou Jinzhao¹,Xu Dandan¹,Wu Man¹,Jiang Shidong¹,Hu Yi³,Tian Ye¹^ORCID,Niu Zhongwei¹⁴^ORCID

Affiliation:

1. Key Laboratory of Photochemical Conversion and Optoelectronic Materials, Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Beijing 100190, China

2. University of Chinese Academy of Sciences, Beijing 100049, China

3. CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China

4. School of Future Technology, University of Chinese Academy of Sciences, Beijing 100049, China

Funder

Ministry of Science and Technology of the People's Republic of China

Natural Science Foundation of Beijing Municipality

Youth Innovation Promotion Association of the Chinese Academy of Sciences

National Natural Science Foundation of China

Key Laboratory of Biomedical Effects of Nanomaterials and Nanosafety

Technical Institute of Physics and Chemistry of the Chinese Academy of Sciences

Publisher

American Chemical Society (ACS)

Subject

General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsami.0c02034

Reference36 articles.

1. Bacteriophage trigger antiviral immunity and prevent clearance of bacterial infection

2. Drug-Driven Phenotypic Convergence Supports Rational Treatment Strategies of Chronic Infections

3. TesG is a type I secretion effector of Pseudomonas aeruginosa that suppresses the host immune response during chronic infection

4. Rapid diversification of Pseudomonas aeruginosa in cystic fibrosis lung-like conditions

5. World Health Organization. WHO Publishes List of Bacteria for Which New Antibiotics Are Urgently Needed. 2017.http://www.who.int/mediacentre/news/releases/2017/bacteria-antibiotics-needed/en/ (accessed May 2017).

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combinatorial therapies of surfactant-like antimicrobial peptides and antibiotics for improved therapeutic efficacy;Current Opinion in Colloid & Interface Science;2024-10

2. Escherichia coli exopolysaccharides disrupt Pseudomonas aeruginosa biofilm and increase its antibiotic susceptibility;Acta Biomaterialia;2024-09

3. Synthesis, Characterization, and Biological Evaluation of Chitosan Nanoparticles Cross-Linked with Phytic Acid and Loaded with Colistin against Extensively Drug-Resistant Bacteria;Pharmaceutics;2024-08-24

4. Breaking Down the Barriers of Drug Resistance and Corneal Permeability with Chitosan-Poly(ethylene glycol)-LK₁₃ Peptide Conjugate to Combat Fungal Keratitis;ACS Infectious Diseases;2024-07-11

5. Programming of macrophage polarization in different stages for accelerating wound healing;Chemical Engineering Journal;2024-07